by Jackie (née Heneghan) Peck | Aug 10, 2017 | Blog, Export Training, Training
If you Export from the UK, have you kept up with the current requirements of GDP? Do you know what the MHRA will expect of you at your next inspection? Do you do the following: Use “EXW” Incoterms? Do you check if the products your customer has collected have been...
by Jackie (née Heneghan) Peck | Jul 31, 2017 | Blog, Pharmacist, Pharmacy Brands, Pharmacy Suppliers
Changes often bring surprises and they need to be risk assessed. This new guidance is in direct conflict with what I have told patients for the thirty years that I have been qualified. When I first qualified the message was pre-printed on labels which we religiously...
by Jackie (née Heneghan) Peck | Jul 31, 2017 | Blog, Brexit
Cries for “QOFXIT” are being heard from the Government and BMA in the same way as people called for Brexit. There is of course a lot of people who would agree, but it would be good to see as full risk assessment of the pros and cons if we have a QOFXIT and a detailed...
by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog
The Nuffield Council on Bioethics recommends that dermal fillers become prescription only. This would mean that they would not be able to be advertised in line with other prescription only medicines. Currently many prescribers order their fillers on prescription,...
by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog
The MHRA have been issuing majors to pharmaceutical wholesalers for several years if they do not have a backup procedure and there is no evidence of it being tested. Loss of data may result in a critical finding if it cannot be produced during an inspection. Why do...
